Sarzuelo, Jovito, JR.. T.

HRN: 21-29-20  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2022
CEFUROXIME 1.5GM (VIAL)
04/30/2022
05/06/2022
IV
1.5gm
Q8
T/C Partial Bowel Obstruction
Waiting Final Action 
04/30/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
04/30/2022
05/06/2022
IV
500mg
Q8
T/C Partial Bowel Obstruction
Waiting Final Action 
05/03/2022
CEFTRIAXONE 1G (VIAL)
05/03/2022
05/10/2022
IV
1g
Q12
Pneumonia
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: